Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > As usual

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on May 07, 2021 11:49am

145 Views

Post# 33152483

RE:RE:As usual

THTX has hired Life Science Advisors to assist with investor relations. It may feel like the same thing day after day now, but that is likely to change soon. If LSA is any good, I imagine they are targeting the annual meeting, and maybe the days leading up to it, as the time to start rebranding TH's stock. We will know soon enough.

stockman75 wrote: No worries Bucknelly. Our board and team has it all under control. No need to vote anyone off it will change. Many things are changing... blah, blah! Faith is one thing on this deal but at momment feels more like blind faith in the board to get this figured out. Meanwhile day after day goes by and same old pattern.

Bucknelly21 wrote: Thtx is the only thing red in a sea of green....